CME Historical Balance Sheet

CME Stock

USD 211.48 1.13 0.54%

Trend analysis of CME Group balance sheet accounts such as Short Long Term Debt Total of 2.4 B, Other Current Liabilities of 98 B or Total Current Liabilities of 98.1 B provides information on CME's total assets, liabilities, and equity, which is the actual value of CME Group to its prevalent stockholders. By breaking down trends over time using CME balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining CME Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether CME Group is a good buy for the upcoming year.

CME Inventory

163.32 Billion

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

About CME Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of CME Group at a specified time, usually calculated after every quarter, six months, or one year. CME Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of CME and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which CME currently owns. An asset can also be divided into two categories, current and non-current.

CME Balance Sheet Chart

CME Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how CME Group uses and utilizes its capital. It also shows what exactly a company owns and owes.

At present, CME's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 98.1 B, whereas Total Stockholder Equity is forecasted to decline to about 17.6 B.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Cash Net Receivables

Add Fundamental

Total Assets

Total assets refers to the total amount of CME assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in CME Group books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on CME balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of CME Group are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Cash

Cash refers to the most liquid asset of CME Group, which is listed under current asset account on CME Group balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from CME customers. The amounts must be unrestricted with restricted cash listed in a different CME account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Most accounts from CME's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into CME Group current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	3.4B	3.4B	3.9B	2.4B
Total Assets	196.8B	174.2B	129.8B	136.3B

Short Long Term Debt Total Total Assets

CME balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock
Total Assets		0.58	0.99	0.99	0.63	-0.06	0.15	0.08	0.58	0.58	0.8	0.55	-0.24	-0.24	0.6	0.02	0.54	0.63	0.55	0.34	-0.29	0.63	1.0	0.35	0.99	0.52
Short Long Term Debt Total	0.58		0.49	0.49	0.9	0.26	0.51	0.71	0.87	0.79	0.56	0.89	0.02	0.05	0.95	0.03	0.44	0.7	0.81	0.76	-0.11	0.89	0.52	0.32	0.49	0.76
Other Current Liab	0.99	0.49		1.0	0.52	-0.12	0.05	-0.01	0.48	0.52	0.75	0.44	-0.28	-0.28	0.5	-0.03	0.51	0.55	0.43	0.21	-0.28	0.52	1.0	0.29	1.0	0.44
Total Current Liabilities	0.99	0.49	1.0		0.52	-0.12	0.04	-0.01	0.49	0.53	0.75	0.44	-0.3	-0.27	0.51	-0.03	0.5	0.55	0.43	0.21	-0.27	0.52	1.0	0.29	1.0	0.44
Total Stockholder Equity	0.63	0.9	0.52	0.52		0.26	0.64	0.5	0.94	0.61	0.6	0.99	0.13	0.08	0.9	0.22	0.33	0.68	0.97	0.89	0.0	1.0	0.56	0.29	0.52	0.78
Other Liab	-0.06	0.26	-0.12	-0.12	0.26		0.33	-0.04	0.19	-0.04	0.35	0.3	0.23	0.88	0.12	0.28	-0.01	0.13	0.32	0.39	0.04	0.26	-0.1	0.12	-0.12	0.15
Property Plant And Equipment Net	0.15	0.51	0.05	0.04	0.64	0.33		0.34	0.63	0.18	0.3	0.67	0.43	0.33	0.47	0.65	0.27	0.22	0.69	0.72	-0.19	0.63	0.08	0.59	0.05	0.24
Net Debt	0.08	0.71	-0.01	-0.01	0.5	-0.04	0.34		0.58	0.62	-0.09	0.52	0.19	-0.07	0.72	0.0	0.2	0.28	0.4	0.47	0.07	0.47	0.02	0.12	-0.01	0.31
Retained Earnings	0.58	0.87	0.48	0.49	0.94	0.19	0.63	0.58		0.61	0.47	0.91	0.18	0.1	0.86	0.29	0.26	0.52	0.86	0.75	0.07	0.9	0.52	0.25	0.49	0.62
Accounts Payable	0.58	0.79	0.52	0.53	0.61	-0.04	0.18	0.62	0.61		0.41	0.57	-0.49	-0.21	0.8	-0.05	0.45	0.48	0.46	0.4	-0.17	0.6	0.55	0.23	0.53	0.5
Cash	0.8	0.56	0.75	0.75	0.6	0.35	0.3	-0.09	0.47	0.41		0.56	-0.2	0.06	0.51	0.05	0.69	0.77	0.62	0.45	-0.53	0.62	0.77	0.6	0.75	0.58
Non Current Assets Total	0.55	0.89	0.44	0.44	0.99	0.3	0.67	0.52	0.91	0.57	0.56		0.17	0.12	0.89	0.23	0.3	0.68	0.98	0.95	0.03	0.99	0.48	0.28	0.44	0.78
Non Currrent Assets Other	-0.24	0.02	-0.28	-0.3	0.13	0.23	0.43	0.19	0.18	-0.49	-0.2	0.17		0.35	-0.06	0.4	-0.17	-0.15	0.19	0.26	0.15	0.1	-0.28	0.07	-0.3	-0.12
Other Assets	-0.24	0.05	-0.28	-0.27	0.08	0.88	0.33	-0.07	0.1	-0.21	0.06	0.12	0.35		-0.11	0.31	-0.29	-0.15	0.12	0.22	0.23	0.06	-0.26	-0.05	-0.27	-0.06
Long Term Debt	0.6	0.95	0.5	0.51	0.9	0.12	0.47	0.72	0.86	0.8	0.51	0.89	-0.06	-0.11		0.06	0.49	0.7	0.82	0.77	-0.13	0.89	0.54	0.34	0.51	0.72
Cash And Short Term Investments	0.02	0.03	-0.03	-0.03	0.22	0.28	0.65	0.0	0.29	-0.05	0.05	0.23	0.4	0.31	0.06		0.05	-0.36	0.26	0.25	-0.06	0.2	-0.01	0.35	-0.02	-0.38
Net Receivables	0.54	0.44	0.51	0.5	0.33	-0.01	0.27	0.2	0.26	0.45	0.69	0.3	-0.17	-0.29	0.49	0.05		0.61	0.33	0.21	-0.91	0.34	0.51	0.88	0.5	0.29
Common Stock Total Equity	0.63	0.7	0.55	0.55	0.68	0.13	0.22	0.28	0.52	0.48	0.77	0.68	-0.15	-0.15	0.7	-0.36	0.61		0.71	0.62	-0.36	0.71	0.58	0.42	0.55	0.87
Common Stock Shares Outstanding	0.55	0.81	0.43	0.43	0.97	0.32	0.69	0.4	0.86	0.46	0.62	0.98	0.19	0.12	0.82	0.26	0.33	0.71		0.95	-0.03	0.98	0.48	0.34	0.44	0.77
Non Current Liabilities Total	0.34	0.76	0.21	0.21	0.89	0.39	0.72	0.47	0.75	0.4	0.45	0.95	0.26	0.22	0.77	0.25	0.21	0.62	0.95		0.07	0.91	0.26	0.27	0.22	0.72
Other Current Assets	-0.29	-0.11	-0.28	-0.27	0.0	0.04	-0.19	0.07	0.07	-0.17	-0.53	0.03	0.15	0.23	-0.13	-0.06	-0.91	-0.36	-0.03	0.07		-0.02	-0.28	-0.89	-0.28	-0.03
Other Stockholder Equity	0.63	0.89	0.52	0.52	1.0	0.26	0.63	0.47	0.9	0.6	0.62	0.99	0.1	0.06	0.89	0.2	0.34	0.71	0.98	0.91	-0.02		0.56	0.3	0.53	0.81
Total Liab	1.0	0.52	1.0	1.0	0.56	-0.1	0.08	0.02	0.52	0.55	0.77	0.48	-0.28	-0.26	0.54	-0.01	0.51	0.58	0.48	0.26	-0.28	0.56		0.31	1.0	0.47
Property Plant And Equipment Gross	0.35	0.32	0.29	0.29	0.29	0.12	0.59	0.12	0.25	0.23	0.6	0.28	0.07	-0.05	0.34	0.35	0.88	0.42	0.34	0.27	-0.89	0.3	0.31		0.29	0.1
Total Current Assets	0.99	0.49	1.0	1.0	0.52	-0.12	0.05	-0.01	0.49	0.53	0.75	0.44	-0.3	-0.27	0.51	-0.02	0.5	0.55	0.44	0.22	-0.28	0.53	1.0	0.29		0.44
Common Stock	0.52	0.76	0.44	0.44	0.78	0.15	0.24	0.31	0.62	0.5	0.58	0.78	-0.12	-0.06	0.72	-0.38	0.29	0.87	0.77	0.72	-0.03	0.81	0.47	0.1	0.44

Click cells to compare fundamentals

CME Account Relationship Matchups

CME balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	75.2B	124.7B	196.8B	174.2B	129.8B	136.3B
Short Long Term Debt Total	3.7B	3.4B	3.4B	3.4B	3.9B	2.4B
Other Current Liab	38.5B	88.1B	159.6B	132.2B	93.3B	98.0B
Total Current Liabilities	38.5B	88.2B	160.4B	137.7B	93.4B	98.1B
Total Stockholder Equity	26.1B	26.3B	27.4B	26.9B	26.7B	17.6B
Other Liab	6.2B	6.7B	6.3B	5.7B	6.6B	6.2B
Property Plant And Equipment Net	544M	579.2M	505.3M	455.5M	681.5M	483.4M
Net Debt	2.2B	1.8B	610.2M	718.3M	966.7M	843.5M
Retained Earnings	5.0B	5.0B	5.2B	4.7B	4.5B	3.0B
Accounts Payable	61.9M	69.3M	48.8M	121.4M	90.6M	51.7M
Cash	1.6B	1.6B	2.8B	2.7B	2.9B	3.1B
Non Current Assets Total	35.6B	35.4B	35.0B	35.1B	34.8B	24.0B
Non Currrent Assets Other	2.1B	2.0B	3.3B	(3.1B)	514.1M	1.0B
Other Assets	545.9M	7.3B	3.3B	574M	134.4M	127.7M
Long Term Debt	3.7B	3.4B	2.7B	3.4B	3.4B	2.5B
Cash And Short Term Investments	1.6B	1.7B	2.9B	2.8B	3.0B	2.7B
Net Receivables	491.8M	461.3M	434.5M	483.2M	1.3B	1.3B
Common Stock Shares Outstanding	358.2M	358.5M	358.9M	359.2M	359.5M	311.9M
Liabilities And Stockholders Equity	75.2B	124.7B	196.8B	174.2B	129.8B	136.3B
Non Current Liabilities Total	10.5B	10.1B	9.0B	9.6B	9.6B	7.4B
Other Current Assets	360.1M	302M	423M	524.9M	(4.3B)	(4.1B)
Other Stockholder Equity	21.1B	21.2B	22.2B	22.3B	22.3B	14.5B
Total Liab	49.1B	98.3B	169.4B	147.3B	103.1B	108.3B
Property Plant And Equipment Gross	544M	579.2M	505.3M	455.5M	1.3B	1.4B
Total Current Assets	39.6B	89.3B	161.8B	139.1B	94.9B	99.6B
Accumulated Other Comprehensive Income	3.4M	134.9M	53.5M	(133.3M)	(55.6M)	(52.8M)
Property Plant Equipment	544M	579.2M	505.3M	837.6M	963.2M	490.1M
Short Term Investments	83.2M	100.9M	115M	96M	111.7M	106.1M
Inventory	37.1B	86.8B	158.0B	135.3B	155.5B	163.3B
Short Term Debt	49.7M	52.2M	749.4M	16M	55.1M	52.3M
Intangible Assets	22.3B	22.0B	20.7B	20.4B	20.2B	18.4B
Good Will	10.7B	10.8B	10.5B	10.5B	10.5B	8.9B
Retained Earnings Total Equity	4.9B	5.0B	5.0B	5.2B	5.9B	3.7B
Deferred Long Term Liab	5.7B	5.6B	5.6B	5.4B	6.2B	4.7B
Net Tangible Assets	(6.9B)	(6.5B)	(3.8B)	(4.0B)	(4.7B)	(4.9B)
Long Term Debt Total	3.8B	3.7B	3.4B	2.7B	3.1B	2.9B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

WD	Walker Dunlop
MSFT	Microsoft
BAC	Bank of America

When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:

How To Invest In CME

Details

Is CME Stock a good investment?

Details

What is CME's Net Worth?

Details

Largest Financial Exchanges & Data Companies

View

Largest Financial Data & Stock Exchanges Companies

View

You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for CME Stock analysis

When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.

	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Stocks Directory Find actively traded stocks across global markets
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals

Is CME's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.03)

Dividend Share

4.45

Earnings Share

8.75

Revenue Per Share

15.638

Quarterly Revenue Growth

0.032

The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CME Historical Balance Sheet

CME Inventory

163.32 Billion

About CME Balance Sheet Analysis

CME Balance Sheet Chart

Total Assets

Total Current Liabilities

Cash

CME balance sheet Correlations

CME Account Relationship Matchups

High Positive Relationship

High Negative Relationship

CME balance sheet Accounts

Also Currently Popular

Complementary Tools for CME Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Other Current Liab
Total Liab	+ 1.0	Other Current Liab
Total Current Assets	+ 1.0	Other Current Liab
Total Liab	+ 1.0	Total Current Liabilities
Total Current Assets	+ 1.0	Total Current Liabilities

Other Current Assets	- 0.91	Net Receivables
Property Plant And Equipment Gross	- 0.89	Other Current Assets
Other Current Assets	- 0.53	Cash
Non Currrent Assets Other	- 0.49	Accounts Payable
Common Stock	- 0.38	Cash And Short Term Investments
Other Current Assets	- 0.36	Common Stock Total Equity